Digital
Enhancing rare disease trials: eCOA technology’s impact on sickle cell research
Sickle cell disease (SCD) affects an estimated 20 million people …
20747 items found
News
Ozempic patient blinded by NAION sues Novo Nordisk
A Maryland man who has lost his vision due to non-arteritic anterior …
News
Akeso PD-1 inhibitor cleared as Keytruda challenger advances
Hong Kong's Akeso has ended the week on a high note, with an FDA …
News
AbbVie files fast-acting Botox successor in US
AbbVie is hoping to extend its range of neurotoxin-based pharma and …
News
Granite Bio makes $100m debut, and other bio financings
Swiss start-up Granite Bio has carved out $100 million in a pair of …
News
MSD has gauged its financial hit from Trump tariffs
MSD is expecting to see an additional $200 million layered onto its …
News
Merck puts a price on its SpringWorks takeover bid
Reacting to press speculation, Merck KGaA has acknowledged that talks …
R&D
Partner Content
4th In Vivo Cell Engineering & Gene Editing Summit
The 4th In Vivo Cell Engineering & Gene Editing Summit , taking place …
Market Access
Partner Content
6th Gene Therapy Analytical Development Summit Europe
The 6th Gene Therapy Analytical Development Summit Europe , taking …
News
Irish study promises to revolutionise childhood cancer care
A five-year genomics study that aims to transform the care of …
News
Can Bioxodes end the dearth of haemorrhagic stroke drugs?
There is currently no approved treatment for intracerebral …
News
Roche seeking talks with the US on tariff exemptions
Roche has said it is petitioning the Trump administration for an …
News
Ozempic patient blinded by NAION sues Novo Nordisk
Novo Nordisk has seen its first lawsuit over the proposed link between Ozempic and the rare eye disorder NAION.
Market Access
Sponsored
Bridging research and clinical guidelines – interactive stra...
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Part 7
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
R&D
Driving the drug discovery pipeline: The value of organ-on-a...
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Tomasz Kostrzewski, CSO at CN Bio, about single organ-on-a-chip technology.
Oncology
Life Sciences Industry Report - Part 5
Developments in the oncology space in 2024 brought hope to both industry and patients.
Sales & Marketing
Partner Content
The ESG in Life Sciences Summit is coming to the West Coast!
The ESG in Life Sciences Summit West is coming to San Francisco! (July 8-10, 2025).
R&D
ISPE Singapore Affiliate Conference & Exhibition 2025
The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most respected events for bio & pharmaceutical manufacturing professionals.
